Cointime

PvP Biologics

company

About

PvP Biologics is developing an oral enzyme for the treatment of celiac disease.

  • 11 - 50

Highlights

Total Funding Amount
$35M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$35M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Nov 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

PvP Biologics is developing an oral enzyme for the treatment of celiac disease. Our mission is to develop a highly-effective therapeutic product to reduce the burden of living with this disease. Towards this end, we are advancing a product candidate designed to break down the immuno-reactive parts of gluten in the stomach and thereby avoid the painful symptoms and damage done in the small intestine from accidental gluten ingestion.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
PvP Biologics has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Jan 5, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 5, 2017 Series Unknown $35M 1 Takeda — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PvP Biologics is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Yes Series Unknown
Cointime
İçerikler
Şirket.